-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2022.
- Aridis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $200K, a 42.7% decline year-over-year.
- Aridis Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $862K, a 52.7% decline year-over-year.
- Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.48M, a 34.3% decline from 2021.
- Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.25M, a 5.78% increase from 2020.
- Aridis Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.13M, a 10.4% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)